YIH
PBH icon

Y-Intercept (HK)’s Prestige Consumer Healthcare PBH Stock Holding History

Y-Intercept (HK)’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-32,635
Closed -$2.04M – 1889
2025
Q3 		$2.04M Buy
32,635
+29,369
+899% +$2.04M 0.05% 593
2025
Q2 		$261K Buy
+3,266
New +$273K 0.01% 1396
2024
Q4 		– Sell
-8,983
Closed -$648K – 1538
2024
Q3 		$648K Buy
+8,983
New +$636K 0.04% 647
2023
Q2 		– Sell
-8,544
Closed -$535K – 1606
2023
Q1 		$535K Buy
+8,544
New +$533K 0.06% 489
2022
Q2 		– Sell
-5,593
Closed -$296K – 1113
2022
Q1 		$296K Buy
+5,593
New +$323K 0.07% 451

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Y-Intercept (HK)'s PBH Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 32,635 shares — an estimated $2.04M sold.

Y-Intercept (HK) first reported a position in PBH in Q1 2022 and held it in 5 quarters. The position peaked at $2.04M in Q3 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Y-Intercept (HK) reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 32,635 Prestige Consumer Healthcare shares in Q4 2025, an estimated $2.04M.
  • Y-Intercept (HK) first reported a position in Prestige Consumer Healthcare in Q1 2022 and held it in 5 quarters.
  • Y-Intercept (HK)'s Prestige Consumer Healthcare position peaked at $2.04M in Q3 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.